Pulmonary infections with nontuberculous mycobacteria

Ugeskr Laeger. 2024 Apr 1;186(14):V06230603. doi: 10.61409/V06230603.
[Article in Danish]

Abstract

This review focuses on the treatment of nontuberculous pulmonary disease caused by Mycobacterium avium complex and M. abscessus. It covers treatment indications, antibiotic choice, resistance and side effects. Treatment of nontuberculous pulmonary disease is complex, lengthy, and fraught with side effects. Increased attention on this disease is needed in order to alleviate the severe consequences of this growing disease. Cooperation between pulmonologists and infectious disease specialists is needed to ensure uniform treatment, and to account for the heterogeneity seen in patients and mycobacteria alike.

Publication types

  • Review
  • English Abstract

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Humans
  • Lung Diseases* / drug therapy
  • Lung Diseases* / microbiology
  • Mycobacterium Infections, Nontuberculous* / drug therapy
  • Nontuberculous Mycobacteria
  • Pneumonia*

Substances

  • Anti-Bacterial Agents